My Quote Request
No products added yet
6505-01-236-6681
20 Products
NDC00071-0375-32
PHENYTOIN SODIUM AND PHENOBARBITAL CAPSULES
NSN, MFG P/N
6505012366681
NSN
6505-01-236-6681
NDC00071-0375-32
PHENYTOIN SODIUM AND PHENOBARBITAL CAPSULES
NSN, MFG P/N
6505012366681
NSN
6505-01-236-6681
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PHENYTOIN SODIUM ACTIVE INGREDIENT AND 16.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00014-1851-90
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012364792
NSN
6505-01-236-4792
NDC00014-1851-90
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012364792
NSN
6505-01-236-4792
MFG
SEARLE G D AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SEARLE CO
Related Searches:
CALAN
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012364793
NSN
6505-01-236-4793
CALAN
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012364793
NSN
6505-01-236-4793
MFG
SEARLE G D AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00014-1861-90
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012364793
NSN
6505-01-236-4793
NDC00014-1861-90
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012364793
NSN
6505-01-236-4793
MFG
SEARLE G D AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
630-03
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012366284
NSN
6505-01-236-6284
630-03
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012366284
NSN
6505-01-236-6284
MFG
DEY LP
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INHALATION SOLUTION USP 3ML VIAL 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 0.9 PCT W/V SODIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
F92I345
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012366284
NSN
6505-01-236-6284
F92I345
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012366284
NSN
6505-01-236-6284
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INHALATION SOLUTION USP 3ML VIAL 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 0.9 PCT W/V SODIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
NDC49502-0630-03
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012366284
NSN
6505-01-236-6284
NDC49502-0630-03
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012366284
NSN
6505-01-236-6284
MFG
DEY LP
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INHALATION SOLUTION USP 3ML VIAL 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 0.9 PCT W/V SODIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
NDC59930-1609-01
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012366284
NSN
6505-01-236-6284
NDC59930-1609-01
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012366284
NSN
6505-01-236-6284
MFG
WARRICK PHARMACEUTICALS INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INHALATION SOLUTION USP 3ML VIAL 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 0.9 PCT W/V SODIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
96520
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012366345
NSN
6505-01-236-6345
96520
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012366345
NSN
6505-01-236-6345
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: FLIP-TOP ADDITIVE SINGLE DOSE VIAL; PRESERVATIVE-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 25
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC00223-8331-20
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012366345
NSN
6505-01-236-6345
NDC00223-8331-20
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012366345
NSN
6505-01-236-6345
MFG
CONSOLIDATED MIDLAND CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: FLIP-TOP ADDITIVE SINGLE DOSE VIAL; PRESERVATIVE-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 25
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC00469-6520-15
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012366345
NSN
6505-01-236-6345
NDC00469-6520-15
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012366345
NSN
6505-01-236-6345
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: FLIP-TOP ADDITIVE SINGLE DOSE VIAL; PRESERVATIVE-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 25
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC00081-0793-99
POLYMYXIN B SULFATE AND BACITRACIN ZINC TOPICAL POWDER,USP
NSN, MFG P/N
6505012366450
NSN
6505-01-236-6450
NDC00081-0793-99
POLYMYXIN B SULFATE AND BACITRACIN ZINC TOPICAL POWDER,USP
NSN, MFG P/N
6505012366450
NSN
6505-01-236-6450
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 UNITS BACITRACIN EQUIVALENT AND 10000.000 UNITS POLYMYXIN B EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN ZINC AND POLYMYCIN B SULFATE TOPICAL POWDER 10GM VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL,SHAKER-TOP
Related Searches:
POLYSPORIN
POLYMYXIN B SULFATE AND BACITRACIN ZINC TOPICAL POWDER,USP
NSN, MFG P/N
6505012366450
NSN
6505-01-236-6450
POLYSPORIN
POLYMYXIN B SULFATE AND BACITRACIN ZINC TOPICAL POWDER,USP
NSN, MFG P/N
6505012366450
NSN
6505-01-236-6450
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 UNITS BACITRACIN EQUIVALENT AND 10000.000 UNITS POLYMYXIN B EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN ZINC AND POLYMYCIN B SULFATE TOPICAL POWDER 10GM VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL,SHAKER-TOP
Related Searches:
CHLOR-TRIMETON
CHLORPHENIRAMINE MALEATE TABLETS,USP
NSN, MFG P/N
6505012366453
NSN
6505-01-236-6453
CHLOR-TRIMETON
CHLORPHENIRAMINE MALEATE TABLETS,USP
NSN, MFG P/N
6505012366453
NSN
6505-01-236-6453
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORPHENIRAMINE MALEATE TABLETS USP 4MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SCHERING LABS
Related Searches:
NDC00085-0080-02
CHLORPHENIRAMINE MALEATE TABLETS,USP
NSN, MFG P/N
6505012366453
NSN
6505-01-236-6453
NDC00085-0080-02
CHLORPHENIRAMINE MALEATE TABLETS,USP
NSN, MFG P/N
6505012366453
NSN
6505-01-236-6453
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORPHENIRAMINE MALEATE TABLETS USP 4MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SCHERING LABS
Related Searches:
NDC00182-0471-01
CHLORPHENIRAMINE MALEATE TABLETS,USP
NSN, MFG P/N
6505012366453
NSN
6505-01-236-6453
NDC00182-0471-01
CHLORPHENIRAMINE MALEATE TABLETS,USP
NSN, MFG P/N
6505012366453
NSN
6505-01-236-6453
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORPHENIRAMINE MALEATE TABLETS USP 4MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SCHERING LABS
Related Searches:
NDC00781-1148-01
CHLORPHENIRAMINE MALEATE TABLETS,USP
NSN, MFG P/N
6505012366453
NSN
6505-01-236-6453
NDC00781-1148-01
CHLORPHENIRAMINE MALEATE TABLETS,USP
NSN, MFG P/N
6505012366453
NSN
6505-01-236-6453
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORPHENIRAMINE MALEATE TABLETS USP 4MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SCHERING LABS
Related Searches:
NDC00186-0243-12
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012366458
NSN
6505-01-236-6458
NDC00186-0243-12
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012366458
NSN
6505-01-236-6458
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIDOCAINE HYDROCHLORIDE INJECTION USP 2% 10ML VIAL 5S
III SUPPLEMENTARY FEATURES: ASTRA MAKES THIS ITEM FOR ABRAXIS, PHARMACEUTICAL PRODUCTS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SINGLE DOSE VIALS
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
XYLOCAINE
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012366458
NSN
6505-01-236-6458
XYLOCAINE
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012366458
NSN
6505-01-236-6458
MFG
ASTRA PHARMACEUTICALS LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIDOCAINE HYDROCHLORIDE INJECTION USP 2% 10ML VIAL 5S
III SUPPLEMENTARY FEATURES: ASTRA MAKES THIS ITEM FOR ABRAXIS, PHARMACEUTICAL PRODUCTS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SINGLE DOSE VIALS
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
DILANTIN
PHENYTOIN SODIUM AND PHENOBARBITAL CAPSULES
NSN, MFG P/N
6505012366681
NSN
6505-01-236-6681
DILANTIN
PHENYTOIN SODIUM AND PHENOBARBITAL CAPSULES
NSN, MFG P/N
6505012366681
NSN
6505-01-236-6681
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PHENYTOIN SODIUM ACTIVE INGREDIENT AND 16.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
